How did the adoption of wP-pentavalent affect the global paediatric vaccine coverage rate? A multicountry panel data

M Mahmud Khan1, Juan Camilo Vargas-Zambrano2, Laurent Coudeville3

  • 1Department of Health Policy and Management, University of Georgia, Athens, Georgia, USA.

BMJ Open
|April 5, 2022
PubMed

Insights

Combination vaccines, like the pentavalent vaccine, significantly boosted global immunization coverage for diphtheria, tetanus, pertussis (DTP3), hepatitis B (HepB3), and Haemophilus influenzae type B (Hib3). These vaccines are crucial for improving childhood vaccine uptake worldwide.

Area of Science:

  • Immunology
  • Global Health
  • Vaccinology

Background:

  • Combination vaccines have been shown to improve immunization coverage at national and subnational levels.
  • The global impact of combination vaccines on immunization coverage has not been extensively studied.

Purpose of the Study:

  • To examine the global effects of introducing the whole-cell pertussis pentavalent (wP-pentavalent) vaccine.
  • To estimate the incremental coverage effects of combination vaccines on diphtheria, tetanus, pertussis (DTP3), hepatitis B (HepB3), and Haemophilus influenzae type B (Hib3) vaccine doses.

Main Methods:

  • Utilized multicountry panel data from WHO/UNICEF, covering the years 1980-2018.
  • Employed linear mixed models to estimate the impact of wP-pentavalent introduction.
  • Incorporated proxy variables to control for time trends and other changes in immunization programs.

Main Results:

  • Introduction of wP-pentavalent vaccine globally increased DTP3 coverage by approximately 3% compared to the pre-combination vaccine era.
  • Combination vaccines improved HepB3 and Hib3 coverage by 10.1% and 9.9%, respectively, in countries that had introduced these antigens earlier.
  • The introduction of pentavalent vaccine facilitated the inclusion of Hib and HepB in the vaccine schedules of a large number of countries.

Conclusions:

  • The development of combination vaccines with additional antigens is likely to sustain and improve coverage for both existing and new childhood vaccines.
  • Combination vaccines play a vital role in enhancing global immunization efforts and expanding vaccine access.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
414
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
875
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
741
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
135